Respiratory syncytial virus (RSV) is increasingly recognized as a major pathogen in frail older adults and a cause of exacerbations of chronic obstructive pulmonary disease (COPD). Although there are studies examining the burden in hospitalized COPD cohorts, there has been no work evaluating the burden in the outpatient setting in this group.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Obesity Treatment
Oral GLP-1 Therapies: ATTAIN-1 and OASIS-4—The Next Leap Forward
- Older patients with atopic dermatitis
Why the Use of Biologics Is Recommended
- Disorders of the Gut-Brain Interaction
Peppermint-Caraway Oil Supplement Proves Effective in Phase IV Trial
- Gepante for Migraines
Relief from pain, symptoms, and improved functional ability—both acute and preventive
- Why the Finerenon Boom Is Giving Hyperkalemia Treatment New Relevance
Potassium binders as enablers of RAASi optimization
- Asthma in Adults: Bronchodilation and Anti-Inflammatory Therapy
Remodeling can be counteracted through a proactive treatment strategy
- From symptom to diagnosis
Gynecomastia and Adipomastia
- Plastic surgery and reconstructive microsurgery for DFS